© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Bullfrog AI Holdings, Inc. Common Stock (BFRG) stock declined over -9.57%, trading at $0.56 on NASDAQ, down from the previous close of $0.62. The stock opened at $0.62, fluctuating between $0.56 and $0.62 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 19, 2026 | 0.61 | 0.63 | 0.57 | 0.62 | 118.62K |
| Mar 18, 2026 | 0.65 | 0.65 | 0.58 | 0.61 | 99.31K |
| Mar 17, 2026 | 0.63 | 0.65 | 0.62 | 0.63 | 103.12K |
| Mar 16, 2026 | 0.59 | 0.65 | 0.59 | 0.62 | 72.25K |
| Mar 13, 2026 | 0.62 | 0.65 | 0.59 | 0.60 | 107.17K |
| Mar 12, 2026 | 0.61 | 0.70 | 0.59 | 0.61 | 107.66K |
| Mar 11, 2026 | 0.62 | 0.68 | 0.60 | 0.62 | 144.03K |
| Mar 10, 2026 | 0.67 | 0.69 | 0.62 | 0.64 | 245.43K |
| Mar 09, 2026 | 0.60 | 0.64 | 0.56 | 0.62 | 203.4K |
| Mar 06, 2026 | 0.57 | 0.62 | 0.56 | 0.59 | 115.41K |
| Mar 03, 2026 | 0.56 | 0.59 | 0.54 | 0.57 | 109.49K |
| Mar 02, 2026 | 0.54 | 0.59 | 0.53 | 0.58 | 149.02K |
| Feb 27, 2026 | 0.62 | 0.62 | 0.56 | 0.58 | 143.02K |
| Feb 26, 2026 | 0.58 | 0.64 | 0.54 | 0.61 | 269.01K |
| Feb 25, 2026 | 0.56 | 0.58 | 0.53 | 0.56 | 150.24K |
| Feb 24, 2026 | 0.55 | 0.56 | 0.52 | 0.55 | 123.71K |
| Feb 23, 2026 | 0.58 | 0.58 | 0.49 | 0.51 | 362.24K |
| Feb 20, 2026 | 0.64 | 0.67 | 0.53 | 0.54 | 596.41K |
| Feb 19, 2026 | 0.57 | 0.68 | 0.55 | 0.64 | 796.44K |
| Feb 18, 2026 | 0.49 | 0.59 | 0.48 | 0.54 | 538.24K |
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
| Employees | 4 |
| Beta | 0.71 |
| Sales or Revenue | $65.00K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |